Childress Capital Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Childress Capital Advisors's VRTX Position: Q2 2026 in Review
Childress Capital Advisors increased its Vertex Pharmaceuticals (VRTX) stake by 3.1% in Q2 2026, buying an estimated $8.42K and bringing the position to 627 shares worth $312K. The position accounts for 0.05% of the portfolio, ranked #264.
Childress Capital Advisors first reported a position in VRTX in Q4 2020 and has held it in 16 quarters since. The position peaked at $388K in Q1 2025. 1,758 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Childress Capital Advisors held 627 shares of Vertex Pharmaceuticals worth $312K as of Q2 2026.
- Childress Capital Advisors bought 19 Vertex Pharmaceuticals shares in Q2 2026, an estimated $8.42K.
- Vertex Pharmaceuticals made up 0.05% of Childress Capital Advisors's portfolio in Q2 2026, its #264 holding.
- Childress Capital Advisors first reported a position in Vertex Pharmaceuticals in Q4 2020 and has held it in 16 quarters since.
- Childress Capital Advisors's Vertex Pharmaceuticals position peaked at $388K in Q1 2025.
- 1,758 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Childress Capital Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.